Abstract

In clinical trials, the bivalent human papillomavirus (HPV) vaccine has high efficacy in preventing cervical HPV-related neoplasia and its precursors,

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call